Technical Analysis for ABOS - Acumen Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
50 DMA Support | Bullish | -2.14% | |
MACD Bullish Centerline Cross | Bullish | -2.14% | |
NR7 | Range Contraction | -2.14% | |
Stochastic Reached Overbought | Strength | -2.14% | |
Upper Bollinger Band Walk | Strength | -2.14% | |
Weak + Overbought | Other | -2.14% | |
Inside Day | Range Contraction | -2.14% | |
Weak, Overbought and Reversal Signs | Reversal | -2.14% |
Alert | Time |
---|---|
Fell Below 50 DMA | 1 day ago |
50 DMA Support | 1 day ago |
Down 3% | 1 day ago |
Fell Below Previous Day's Low | 1 day ago |
Down 2 % | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/14/2024
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.3099 |
52 Week Low | 1.8101 |
Average Volume | 265,113 |
200-Day Moving Average | 3.91 |
50-Day Moving Average | 3.71 |
20-Day Moving Average | 3.40 |
10-Day Moving Average | 3.55 |
Average True Range | 0.23 |
RSI (14) | 54.13 |
ADX | 20.11 |
+DI | 23.67 |
-DI | 19.03 |
Chandelier Exit (Long, 3 ATRs) | 3.24 |
Chandelier Exit (Short, 3 ATRs) | 3.75 |
Upper Bollinger Bands | 3.81 |
Lower Bollinger Band | 2.98 |
Percent B (%b) | 0.8 |
BandWidth | 24.54 |
MACD Line | 0.02 |
MACD Signal Line | -0.04 |
MACD Histogram | 0.0621 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.96 | ||||
Resistance 3 (R3) | 3.96 | 3.87 | 3.91 | ||
Resistance 2 (R2) | 3.87 | 3.79 | 3.86 | 3.89 | |
Resistance 1 (R1) | 3.76 | 3.74 | 3.71 | 3.75 | 3.87 |
Pivot Point | 3.66 | 3.66 | 3.63 | 3.66 | 3.66 |
Support 1 (S1) | 3.55 | 3.58 | 3.50 | 3.55 | 3.43 |
Support 2 (S2) | 3.45 | 3.53 | 3.45 | 3.41 | |
Support 3 (S3) | 3.34 | 3.45 | 3.39 | ||
Support 4 (S4) | 3.34 |